KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 81 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 1.33 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $12,938,000 | +15.9% | 1,376,355 | +20.0% | 0.00% | 0.0% |
| Q3 2016 | $11,163,000 | +55.5% | 1,147,261 | +7.2% | 0.00% | 0.0% |
| Q2 2016 | $7,178,000 | -23.9% | 1,069,779 | +1.1% | 0.00% | 0.0% |
| Q1 2016 | $9,436,000 | -31.5% | 1,057,872 | +1.8% | 0.00% | -33.3% |
| Q4 2015 | $13,774,000 | +17.3% | 1,039,544 | -6.8% | 0.00% | 0.0% |
| Q3 2015 | $11,745,000 | -59.5% | 1,115,412 | +4.8% | 0.00% | -57.1% |
| Q2 2015 | $28,969,000 | +8.8% | 1,064,628 | +22.4% | 0.01% | +16.7% |
| Q1 2015 | $26,617,000 | -7.1% | 869,544 | +13.6% | 0.01% | -14.3% |
| Q4 2014 | $28,648,000 | +154.3% | 765,388 | +137.4% | 0.01% | +133.3% |
| Q3 2014 | $11,265,000 | -20.9% | 322,396 | +5.3% | 0.00% | -25.0% |
| Q2 2014 | $14,249,000 | +108.7% | 306,097 | +38.5% | 0.00% | +100.0% |
| Q1 2014 | $6,828,000 | +39.7% | 221,048 | +3.7% | 0.00% | +100.0% |
| Q4 2013 | $4,887,000 | – | 213,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |